There are 76 news based on search keyword " pharmaceutical "

Singapore Upgrades 2025 GDP Growth Forecast To 1.5 To 2.5 Pct

SINGAPORE, Aug 12 (Bernama) --  Singapore has upgraded its 2025 gross domestic product (GDP) growth forecast to 1.5 to 2.5 per cent to reflect the better-than-expected performance of the country’s economy in the first half of 2025 (1H 2025).

Ringgit Likely To Trade Cautiously Next Week Amid US Tariff Concerns

KUALA LUMPUR, Aug 9 (Bernama) -- The ringgit is anticipated to trade cautiously against the dollar next week as investors monitor external developments, particularly regarding United States tariffs.

Pharmaniaga Completes Regularisation Plan, Set To Exit PN17 By 1Q 2026

KUALA LUMPUR, Aug 6 (Bernama) -- Pharmaniaga Bhd has completed its Practice Note 17 (PN17) regularisation plan following the completion of its capital reduction exercise through the cancellation of RM520 million in issued share capital.

IHW 2025 Generates RM96.18 Mln in Sales For Malaysian Healthcare Firms

KUALA LUMPUR, Aug 6 (Bernama) -- Malaysian healthcare companies recorded RM96.18 million in sales during the International Healthcare Week (IHW) 2025, held from July 16 to 18 at the Malaysia International Trade and Exhibition Centre (MITEC).

Bursa Malaysia Opens Lower On US Tariff Concerns, Wall Street Decline

By Danni Haizal Danial Donald

KUALA LUMPUR, Aug 6 (Bernama) -- Bursa Malaysia opened slightly lower on Wednesday, tracking Wall Street’s decline as sentiment turned cautious following weak US economic data and tariff announcements by President Donald Trump on the semiconductor and pharmaceutical sectors.

Bursa Malaysia Opens Lower On Concerns Over Weaker US Economic Data

KUALA LUMPUR, Aug 4 (Bernama) -- Bursa Malaysia retreated from last week’s gains to open lower on Monday, tracking Wall Street’s losses last Friday as investors remain concerned over weaker US economic data coupled with impacts from President Donald Trump’s tariff war.

Semiconductor, Pharma Sectors Exempt From US Tariff For Now - Tengku Zafrul 

KUALA LUMPUR, Aug 1 (Bernama) -- Semiconductor and pharmaceutical exports to the United States (US) are exempt from the 19 per cent tariff for now, said Minister of Investment, Trade and Industry Tengku Datuk Seri Zafrul Tengku Abdul Aziz.

Pharmaniaga On Track To Exit PN17, Jakel Medical Emerges As New Substantial Shareholder

KUALA LUMPUR, July 31 (Bernama) -- Pharmaniaga Bhd has completed two critical milestones of its regularisation plan, the rights issue and private placement, thus positioning the group firmly on track to exit its Practice Note 17 (PN17) status.

CIMB, Pharmaniaga Team Up To Boost Financial Flexibility For Healthcare SMEs

KUALA LUMPUR, July 18 (Bernama) -- CIMB Bank Bhd has signed a collaboration agreement with Pharmaniaga Logistics Sdn Bhd, a wholly owned unit of Pharmaniaga Bhd (Pharmaniaga), to enhance supply chain financing and ease payment flexibility for small and medium enterprises (SMEs) in the healthcare sector.

IHW 2025 Reflects Malaysia's Commitment To Drive Innovation In Healthcare Industry - Tengku Zafrul

KUALA LUMPUR, July 16 (Bernama) -- The International Healthcare Week (IHW) 2025 reflects Malaysia's commitment to driving innovation, accelerating growth, and forging global partnerships that will define the next chapter of the country’s healthcare industry.

Pharma Industry Emerging As Driver Of Investments, Jobs, And Healthcare Resilience -- MPC

KUALA LUMPUR, June 30 (Bernama) -- Malaysia’s pharmaceutical industry is emerging as a driver of high-value investment, skilled employment, and healthcare resilience, driven by regulatory and productivity reforms implemented in recent years, according to the Malaysia Productivity Corporation (MPC).

Spring Bio Solution Launches First Free Pharma Intelligence Platform

KUALA LUMPUR, June 12 (Bernama) -- Spring Bio Solution, a global leader in comparator sourcing and clinical trial supplies, has launched NCE Grid, touted as the world’s first free new chemical entity (NCE-1) intelligence platform — built to decode, centralise, and visualise Paragraph IV (Para IV) opportunities in real-time.